Overview of the Orthofix Medical Class Action Lawsuit
Orthofix Medical, Inc. (NASDAQ: OFIX) finds itself at the center of a notable class action lawsuit. Investors who purchased shares during a specified timeframe are facing a crucial deadline. Legal representatives for the affected investors are reminding individuals of their rights and available options in this case.
Who is Kahn Swick & Foti, LLC?
Kahn Swick & Foti, LLC (KSF) is a boutique law firm focused on securities litigation, and they have stepped up to represent investors impacted by the concerns surrounding Orthofix. Led by managing partner Lewis Kahn, a former Attorney General, KSF has a established history of advocating for investor rights in the face of corporate misconduct.
Investor Deadline Approaching
Investors who have suffered losses greater than $100,000 from their investments in Orthofix are urged to act without delay. The deadline to submit a lead plaintiff application is quickly approaching, with a cutoff set for October 21. Those interested in taking on this role are encouraged to do so promptly, as it may allow them to influence the direction of the lawsuit.
The Allegations Explained
The lawsuit asserts that during the class period from October 11, 2022, to September 12, 2023, Orthofix and its executives failed to inform shareholders about vital information. These omissions have significant consequences for investors, directly affecting stock prices and leading to considerable financial losses.
Background of the Lawsuit
On September 12, 2023, Orthofix appointed new executives after dismissing several key figures due to allegations of inappropriate conduct. This decision came after an independent investigation, raising concerns among investors and causing a sharp decline in share prices. Following the announcement, Orthofix's stock plummeted by over 30%, underscoring the serious effect of corporate governance on investor trust.
Steps for Affected Investors
If you purchased shares in Orthofix during the class period and want to discuss your legal rights in relation to this lawsuit, consider reaching out to KSF. They offer a no-obligation consultation to evaluate your situation and the possible consequences of the class action on your investments.
Contacting Kahn Swick & Foti, LLC
If you'd like to learn more or explore your options, KSF provides contact details for Lewis Kahn, who is available toll-free. Whether you prefer to call or email, seeking legal advice is an important step for all affected investors as they navigate this complicated situation.
About Orthofix Medical
Orthofix is a global company that develops innovative medical devices for the spine and extremities. Their mission focuses on improving patient quality of life through advanced medical technologies. Nonetheless, this ongoing legal matter poses challenges to that mission, making it crucial for the company to handle these allegations appropriately in order to restore investor confidence.
Frequently Asked Questions
What is the class action lawsuit against Orthofix about?
The lawsuit claims that Orthofix did not disclose crucial information that negatively affected shareholders during a specific timeframe.
Who can file a claim in the class action?
Investors who bought shares of Orthofix between October 11, 2022, and September 12, 2023, and experienced losses over $100,000 are eligible to file as lead plaintiffs.
What is the deadline to apply for lead plaintiff status?
Investors must submit their applications by October 21 to be considered for lead plaintiff status in the class action.
Who is representing the investors in this lawsuit?
Kahn Swick & Foti, LLC, under the leadership of Lewis Kahn, is representing the investors involved in the class action against Orthofix Medical.
How can I contact Kahn Swick & Foti, LLC?
Affected investors can reach the firm toll-free to discuss their legal rights and the possible implications of the lawsuit.
